Compartmentalized Protective and Detrimental Effects of Endogenous Migration-Inhibitory Factor Mediated by CXCR2 in a Mouse Model of Myocardial Ischemia/Reperfusion
Objective—Here, we aimed to clarify the role of CXCR2 in macrophage migration-inhibitory factor (MIF)–mediated effects after myocardial ischemia and reperfusion. As a pleiotropic chemokine-like cytokine, MIF has been identified to activate multiple receptors, including CD74 and CXCR2. In models of myocardial infarction, MIF exerts both proinflammatory effects and protective effects in cardiomyocytes. Similarly, CXCR2 displays opposing effects in resident versus circulating cells.
Approach and Results—Using bone marrow transplantation, we generated chimeric mice with CXCR2−/− bone marrow–derived inflammatory cells and wild-type (wt) resident cells (wt/CXCR2−/−), CXCR2−/− cardiomyocytes and wt bone marrow–derived cells (CXCR2−/−/wt), and wt controls reconstituted with wt bone marrow (wt/wt). All groups were treated with anti-MIF or isotype control antibody before they underwent myocardial ischemia and reperfusion. Blocking MIF increased infarction size and impaired cardiac function in wt/wt and wt/CXCR2−/− mice but ameliorated functional parameters in CXCR2−/−/wt mice, as analyzed by echocardiography and Langendorff perfusion. Neutrophil infiltration and angiogenesis were unaltered by MIF blockade or CXCR2 deficiency. Monocyte infiltration was blunted in wt/CXCR2−/− mice and reduced by MIF blockade in wt/wt and CXCR2−/−/wt mice. Furthermore, MIF blockade attenuated collagen content in all groups in a CXCR2-independent manner.
Conclusions—The compartmentalized and opposing effects of MIF after myocardial ischemia and reperfusion are largely mediated by CXCR2. Although MIF confers protective effects by improving myocardial healing and function through CXCR2 in resident cells and complementing paracrine effects through CD74/AMPK, it exerts detrimental effects on CXCR2-bearing inflammatory cells by increasing monocyte infiltration and impairing heart function. These dichotomous findings should be considered when developing novel therapeutic strategies to treat myocardial infarction.
- CXCR2 receptors
- ischemia-reperfusion injury
- macrophage migration-inhibitory factors
- myocardial infarction
- Received April 2, 2013.
- Accepted July 3, 2013.
- © 2013 American Heart Association, Inc.